Artelo Biosciences Says ART27.13 Cut Body Weight About 20% In Obese Mice, Matching Semaglutide; Combination With Semaglutide Produced About 40% Weight Loss
Share
Why It Matters
Artelo's experimental drug cut mouse weight by about 20 percent. Combined with semaglutide, it achieved roughly 40 percent weight loss in tests.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.